153 related articles for article (PubMed ID: 2377284)
1. The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors.
Altschuler E; Moosa H; Selker RG; Vertosick FT
Neurosurgery; 1990 Jul; 27(1):74-6; discussion 77. PubMed ID: 2377284
[TBL] [Abstract][Full Text] [Related]
2. Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Anticoagulants or inferior vena cava filter?
Olin JW; Young JR; Graor RA; Ruschhaupt WF; Beven EG; Bay JW
Arch Intern Med; 1987 Dec; 147(12):2177-9. PubMed ID: 3500686
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulants, venous thromboembolism, and the cancer patient.
Moore FD; Osteen RT; Karp DD; Steele G; Wilson RE
Arch Surg; 1981 Apr; 116(4):405-7. PubMed ID: 6971083
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with anticoagulant therapy during pregnancy.
Hirsh J; Cade JF; O'Sullivan EF
Br Med J; 1970 Jan; 1(5691):270-3. PubMed ID: 5416615
[TBL] [Abstract][Full Text] [Related]
5. [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications].
Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Khasanova ZB; Postnov AIu; Kirienko AI
Ter Arkh; 2011; 83(12):43-8. PubMed ID: 22416444
[TBL] [Abstract][Full Text] [Related]
6. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
Norden AD; Bartolomeo J; Tanaka S; Drappatz J; Ciampa AS; Doherty LM; Lafrankie DC; Ruland S; Quant EC; Beroukhim R; Wen PY
J Neurooncol; 2012 Jan; 106(1):121-5. PubMed ID: 21706358
[TBL] [Abstract][Full Text] [Related]
7. Bleeding diverticulosis in patients on oral anticoagulants.
Parsa F; Wilson SE
Am J Surg; 1974 Jun; 127(6):708-10. PubMed ID: 4545538
[No Abstract] [Full Text] [Related]
8. Anticoagulant therapy in right-sided thromboembolic disease.
Robin ED; Burke CM
Chest; 1986 Jun; 89(6):882-4. PubMed ID: 3519111
[No Abstract] [Full Text] [Related]
9. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
Carter BL; Jones ME; Waickman LA
Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
[TBL] [Abstract][Full Text] [Related]
10. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
11. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
[TBL] [Abstract][Full Text] [Related]
12. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant-related hemorrhage in acute cerebral embolism.
Shields RW; Laureno R; Lachman T; Victor M
Stroke; 1984; 15(3):426-37. PubMed ID: 6729870
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
15. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
Meinhold JM; Reale EO; Miller WA
Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary embolism after brain hemorrhage in a hypertensive patient: the therapeutic dilemma.
Oneglia C; Gualeni A
J Thromb Thrombolysis; 2008 Apr; 25(2):231-4. PubMed ID: 17534695
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy].
Enrico JF
Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910
[TBL] [Abstract][Full Text] [Related]
18. [Intracranial hemorrhage due to pulmonary thromboembolism in heparin therapy and therapeutic management of patients hospitalized with massive pulmonary embolism after discharge].
Beşli F; Keçebaş M; Alişir MF; Güngören F
Turk Kardiyol Dern Ars; 2013 Apr; 41(3):228-32. PubMed ID: 23703559
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation. Current approach to heparin and warfarin therapy.
Painter TD
Postgrad Med; 1983 Sep; 74(3):341-5, 348, 350. PubMed ID: 6889207
[TBL] [Abstract][Full Text] [Related]
20. Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation.
Tapanainen JM; Braunschweig F; Schwieler J; Insulander P; Bastani H; Drca N; Kennebäck G; Sadigh B; Jensen-Urstad M
Scand Cardiovasc J; 2013 Apr; 47(2):109-13. PubMed ID: 23098247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
